Cerebrovascular Disease
Cerebrovascular Disease is presented as a cardiovascular condition, with focused information intended as a clearer starting point. It is the condition being considered alongside options such as Melatonin, Vitamin B1 (Thiamine), and Tai Chi.
Cerebrovascular Disease is presented here as a cardiovascular condition, with focused information for a clearer starting point.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
None of these options has good evidence yet. Best evidence first.
2 options:1 not enough evidence1 no benefit found
PsychotherapypracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A single-group study in 30 children with MMD found improvements in quality of life and caregiver knowledge after counseling. Without a control group, the study authors noted that causality cannot be firmly established.
Open the Psychotherapy pageTai ChipracticeNo benefit found
Studies looked for a benefit and did not find one.
The one study found no benefit.
Open the Tai Chi page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition2 listedThe best we have, but the evidence is still weak
- →PracticesPsychotherapyCertaintyLowSourceClinical
A single-group study in 30 children with MMD found improvements in quality of life and caregiver knowledge after counseling. Without a control group, the study authors noted that causality cannot be firmly established.
Who was studied
- People with a condition
Open PsychotherapyStudy result
Quasi-experimental single-group study (n=30 children with MMD) showing significant pre-post improvements in PedsQL total and all domains (p<0.001) and caregiver knowledge after counseling; authors note causality cannot be firmly established due to absence of control group.
Very low probability(1)
- →PracticesTai ChiCertaintyVery lowSourceRCT
Pooled analyses whose designs were not recorded did not support improvement: the reported MD was −0.54, 95% CI −1.58 to 0.51, P = 0.31, with insufficient evidence of improvement.
Open Tai ChiWho was studied
- People with a condition
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making Cerebrovascular Disease worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Cerebrovascular Disease is presented as a cardiovascular condition, with focused information intended as a clearer starting point. It is the condition being considered alongside options such as Melatonin, Vitamin B1 (Thiamine), and Tai Chi.
Evidence-backed options
The options associated with Cerebrovascular Disease differ substantially in how directly they have been studied in people. Melatonin has been proposed as a treatment for cerebral ischemia–reperfusion injury, but the evidence described comes from animal research, so its relevance to people with cerebrovascular disease remains uncertain. The information provided does not establish how quickly effects might appear or how long treatment was used.
Vitamin B1 (Thiamine) has been studied in patients with critical cerebrovascular conditions. Its use was associated with lower short-term mortality, particularly with prolonged treatment and reduced daily doses. However, the available description does not provide an exact treatment duration, dose, or time to effect, and an association does not by itself establish that supplementation caused the outcome.
Tai Chi has been evaluated in people with a clinical condition, but the finding indicates insufficient evidence of improvement. Together, these findings show that the options are not supported equally: some evidence is from animal research, some is observational or correlational in critically ill patients, and the exercise evidence remains uncertain. Anyone considering these options for a medical condition should discuss the relevant evidence and treatment context with a clinician.